170 related articles for article (PubMed ID: 11702748)
1. New drugs for treating CMV. Valcyte, an oral compound, expands the treatment options for people with CMV retinitis.
Eagan L
Posit Living; 2001; 10(6):13. PubMed ID: 11702748
[No Abstract] [Full Text] [Related]
2. New treatment options for CMV retinitis in AIDS.
Lalezari JP
Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
[No Abstract] [Full Text] [Related]
3. Sustained remission of CMV retinitis in HIV-2 disease.
Papadopoulou VI; Shah SM
Br J Ophthalmol; 2000 Dec; 84(12):1437. PubMed ID: 11186865
[No Abstract] [Full Text] [Related]
4. Subretinal hemorrhage associated with cytomegalovirus retinitis in a patient without concurrent thrombocytopenia.
Beck AP; Ravage ZB; Richmond CA
Retina; 2004 Aug; 24(4):611-3. PubMed ID: 15300084
[No Abstract] [Full Text] [Related]
5. Valganciclovir: a new treatment for cytomegalovirus retinitis.
Marco M
BETA; 2002; 15(1):19-21. PubMed ID: 12141246
[No Abstract] [Full Text] [Related]
6. CMV trial enrolling.
Vazquez E
Posit Aware; 1997; 8(4):13. PubMed ID: 11364480
[TBL] [Abstract][Full Text] [Related]
7. Use of ganciclovir implants for CMV retinitis in an 18-month-old child with AIDS.
Dalton R; Aylward GW; Sharland M
Eye (Lond); 1999; 13 ( Pt 1)():110-2. PubMed ID: 10396395
[No Abstract] [Full Text] [Related]
8. FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration.
Baker R
BETA; 1995 Dec; ():8. PubMed ID: 11363015
[TBL] [Abstract][Full Text] [Related]
9. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
10. [Hexal expands its antiviral portfolio].
Red
MMW Fortschr Med; 2016 May; 158(10):90. PubMed ID: 27221453
[No Abstract] [Full Text] [Related]
11. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
Jacobson MA
Adv Exp Med Biol; 1996; 394():85-92. PubMed ID: 8815712
[No Abstract] [Full Text] [Related]
12. CMV retinitis trial expanding.
Vazquez E
Posit Aware; 1998; 9(1):16. PubMed ID: 11364995
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
Danner SA; Matheron S
AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
[TBL] [Abstract][Full Text] [Related]
14. The changing treatment options for CMV retinitis.
Gilden D
GMHC Treat Issues; 1995; 9(7/8):1-8. PubMed ID: 11362648
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS.
Akula SK; Ma PE; Peyman GA; Rahimy MH; Hyslop NE; Janney A; Ashton P
Br J Ophthalmol; 1994 Sep; 78(9):677-80. PubMed ID: 7947546
[TBL] [Abstract][Full Text] [Related]
16. Corneal infiltration and CMV retinitis in a patient with AIDS.
Inoue T; Hayashi K; Omoto T; Kosaki R; Higaki S; Shimomura Y
Cornea; 1998 Jul; 17(4):441-2. PubMed ID: 9676918
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa.
Hassan-Moosa R; Chinappa T; Jeena L; Visser L; Naidoo K
S Afr Med J; 2017 Sep; 107(10):843-846. PubMed ID: 29022526
[TBL] [Abstract][Full Text] [Related]
18. Ocular manifestations of AIDS.
Whitcup SM
JAMA; 1996 Jan; 275(2):142-4. PubMed ID: 8531310
[No Abstract] [Full Text] [Related]
19. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
[No Abstract] [Full Text] [Related]
20. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
